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Abstract: 
 
Aims of the study: Pre-eclampsia (PE) is characterized by an altered maternal cardiovascular 
adaptation to pregnancy and increased cardiovascular risk later on in life. The aim of the current 
study was to compare arterial stiffness in women with pre-eclampsia and those with normotensive 
pregnancies. 
Methods This was a cross sectional study involving 69 normotensive, pregnant women and 54 
women with preeclampsia. Maternal wave reflection (augmentation index; AIx) and pulse wave 
velocity (PWV) of the carotid-radial and carotid-femoral part of the arterial tree were assessed non-
invasively using applanation tonometry.  
Results Compared to normotensive pregnant controls, women with pre-eclampsia had significantly 
increased AIx (4±13.6% vs 24.3±10.3%, p<0.0001) and current PE was significantly (p<0.0001) 
and independently associated with increased wave reflection in a model that also included 
maternal age (p=0.002), heart rate (p<0.0001), gestational age at entry (p= 0.03) and aortic Tr 
(p<0.0001). The PWV (carotid-femoral and carotid-radial) were significantly higher in women with 
pre-eclampsia (7.21.2m/sec vs 5.5±0.7m/sec, p<0.0001 and 9.41m/sec  vs 7.51.2m/sec, 
p<0.0001 respectively) and pre-eclampsia was significantly (p<0.0001) and independently 
associated with increased PWV (carotid-femoral) in a model that also included maternal age 
(p<0.0001), mean arterial pressure (p<0.0001) and black race (p<0.0001). The results were similar 
for PWV of the carotid-radial. There was no statistical significant difference in the above 
parameters between women with early (before 34 weeks of gestation) and late onset PE.  
 
Conclusions  Pre-eclampsia is characterized by increased maternal wave reflection and arterial 
stiffness. 
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INTRODUCTION:  
The cardiovascular system undergoes important modifications in pregnancy with increased blood 
volume, cardiac output and heart rate as well as reduced blood pressure and vascular resistance. 
All these modifications occur in order to ensure adequate uteroplacental supply.(1)  
Plasma volume expansion and increased cardiac output are thought to be triggered or preceded by 
the decrease in systemic vascular resistance. Schrier et all (2,3) hypothesized that the primary 
event in normal pregnancy is peripheral arterial vasodilatation which leads to a state of relative 
underfilling of the arterial circulation with subsequent renal sodium and water retention and 
consequently expansion of the extracellular and plasma volume.  
A decrease in vascular resistance and the generalised vasodilatation affect arterial stiffness. In 
normal pregnancy arterial stiffness decreases during the first trimester and remains low until the 
end of pregnancy due to either reduced smooth muscle tone or vessel wall remodelling. (4) 
Pre-eclampsia is one of the leading causes of maternal and perinatal morbidity and mortality. It 
occurs in 3-10% of all pregnancies (5) and is associated with reduced plasma volume, increased 
vascular resistance and vasoconstriction. 
It is defined as blood pressure of 140/90 mmHg on two consecutive occasions at least 4 hours 
apart associated with proteinuria of at least 300 mg per 24 h or 2+ on dipstick.(6) 
Recent studies report increased arterial stiffness both with age and in patients with increased 
cardiovascular risk due to certain diseases such as hypertension, diabetes and 
hypercholesterolemia.(7,9).These are known to cause endothelial dysfunction hence reducing 
arterial compliance. Changes have also been observed prior to the appearance of a clinically 
apparent disease therefore this method is likely to be useful in risk assessment for myocardial 
infarction and stroke. 
Non invasive evaluation of aortic stiffness is possible with a simple, validated and reproducible 
technique of applanation tonometry. (10,11) Pulse wave analysis (PWA) and pulse wave velocity 
(PWV) can be performed. The aortic waveform, peripheral and central pressures are derived using 
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a transfer function from the assessment of the radial artery waveform. (12,13) hence the 
augmentation index (AI) a marker of vascular compliance is obtained. On the other hand, PWV is 
the speed at which the pressure wave is transmitted from the aorta through the vascular tree and 
the stiffer the vessels the higher the velocity. 
Since pre-eclampsia is related with increased peripheral vascular resistance as with these 
diseases the objective of our study was that of evaluating whether the patients with pre-eclampsia 
had stiffer arteries than control subjects and if this method would eventually be useful in detecting 
women with, or at increased risk of pre-eclampsia earlier.  
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Indices of arterial stiffness 
Term  Definition Methods of measurement 
Elastic modulus** The pressure change required 
fore theoretical 100% stretch from 
resting diameter  
(P x D)/ D (mmHg)  
Ultrasound* 
MRI 
Young’s modulus ** Elastic modulus per unit area (P 
x D)/ D x h) (mmHg/cm) 
Ultrasound* 
MRI 
Arterial distensibility ** Relative change in diameter (or 
area) for a given pressure 
change; inverse of elastic 
modulus D/ (P x D)(mmHg -1) 
Ultrasound* 
MRI 
Arterial compliance** Absolute diameter (or area) 
change for a given pressure step 
D/P (cm/mmHg)  
(or cm2 / mmHg) 
Ultrasound* 
MRI 
Pulse wave velocity Velocity of travel of the pulse 
along a length of artery  
Distance/ t (cm/sec) 
Pressure waveform* 
Volume waveform 
Ultrasound 
MRI 
Augmentation index The difference between the 
second and first systolic peaks as 
a % of pulse pressure 
Pressure waveform* 
Stiffness index (ß) ** Ratio of In (systolic/diastolic 
pressures) to (relative change in 
diameter) ß= In ( Ps/Pd) 
                    (Ds – Dd)/ Dd 
Ultrasound * 
Capacitative compliance  Relationship between pressure 
change and volume change in the 
arteries during the exponential 
component of diastolic pressure 
decay V/P (cm3/mmHg) 
Pressure waveform* 
Oscillatory compliance Relationship between oscillating 
pressure change and oscillating 
volume change around the 
exponential pressure decay 
during diastole 
V/P (cm3/mmHg) 
Pressure waveform* 
 
P, pressure; D, diameter; V, volume; h, wall thickness; t, time; v, velocity; s, systolic; d, diastolic. * most common method of 
measurement, ** also requires pressure measurements 
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METHODS OF MEASURING ARTERIAL STIFFNESS 
PULSE PRESSURE: 
This is given by the difference between systolic and diastolic blood pressures and depends on the 
cardiac output, large artery stiffness and wave reflection. It was recognized already in the 1920s by 
Bramwell and coll ( 14) as a surrogate for arterial stiffness. Pulse pressure has however shown to 
be an unreliable method as it varies along the arterial tree. In-fact it gets amplified as it travels from 
the aorta to the periphery and therefore measurements of the latter do not accurately reflect the 
actual central pulse pressure. Moreover since the heart, brain and kidneys are affected by the 
aortic pressure, the cardiovascular risk is more accurately related to the central blood pressure.  
Central blood pressure can be measured invasively using intra-arterial catheters, however non-
invasive validated methods which are simple, feasible and reproducible are now available. 
 
ULTRASOUND- DERIVED INDICES 
Ultrasound can be used to measure arterial stiffness ( distensibility and compliance) . Its use 
however is limited to the larger and more accessible arteries. It has been used mainly on the 
brachial, femoral , carotid and abdominal aorta. Several images of the vessel wall are obtained per 
cardiac cycle and the maximum and minimum areas of the vessel are calculated. Distensibility and 
hence compliance (inverse of stiffness) can be calculated using the following formulae: 
 
Distensibility =   V  
                                                                                         P.V 
 
Compliance =   V 
                         P 
 
Where v = change in volume, p = change in pressure, and V = volume 
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Use of ultrasound however is not feasible as the resolution is limited making the detection of very 
small changes in the vessel diameter difficult to detect. It therefore requires an experienced 
operator and expensive equipment. 
 
MAGNETIC RESONANCE IMAGING (MRI) 
This technique has recently been used to measure vascular distensibility and compliance. Most of 
the studies have been on the aorta: MRI has been used to demonstrate the inverse relationship 
between aortic distensibility and age, reduced arterial compliance in hypertensive patients (15) and 
in those with coronary artery disease while its increased in athletes.(16)  
MRI however remains expensive and therefore its use remains limited to research studies. 
 
WAVEFORM ANALYSIS. 
Arterial pressure waveform is a composite of the forward pressure produced by ventricular 
contraction and a reflected wave. Reflected waves come from the periphery principally from branch 
points or sites of impendance mismatch. The arterial waveform will therefore vary throughout the 
arterial tree. The velocity at which this waveform travels is influenced by the stiffness of the arteries 
and therefore the stiffer the arteries the higher the velocity. 
In elastic vessels, the reflected wave arrives back to the aorta during diastole, serving to increase 
diastolic pressure and consequently improving coronary artery perfusion.  
On the contrary, with stiff arteries, the reflected wave arrives back to the central arteries earlier, 
increasing systolic pressure and a consequent decrease in diastolic pressure. High systolic 
pressures accelerate the development of left ventricular hypertrophy, whereas low diastolic 
pressures reduce coronary artery perfusion. The amplitude of the reflected wave increases as the 
arterial stiffness increases further augmenting central systolic pressure. 
The O’Rourke Pulse wave Analysis (PWA) system is a simple, non invasive, validated method of 
measuring arterial stiffness.(17) Applanation tonometry is used to record pressures in the 
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peripheral arteries and a validated generalised transfer factor is then applied to derive the 
corresponding central waveform. The principle behind this is that when a curved surface of a 
cylinder is flattened, the circumferential pressures are equalized and intraluminal pressures can be 
recorded accurately. In practise, a pencil-like probe, with a high fidelity micromanometer at its tip is 
applied to the skin above the artery and gentle downwards pressure is used to flatten the artery 
against the underlying tissues.  
 
 
 
Augmentation index, which is the difference between the first and second systolic peaks, 
( the first systolic peak is the maximum pressure given by the forward going pressure wave while 
the second is  the sum of the forward and backward going waveforms) expressed as a percentage 
of the pulse pressure, and a measure of systemic stiffness can then be derived .(18) 
The inflection point on the upward part of the systolic part of the systolic curve is caused by the 
start of wave reflection. Since the main site of wave reflection is the aortic bifurcation, 
determination of the inflection point provides a measure of aortic pulse wave velocity. (19) By 
integrating the pressure-time signal, the mean arterial pressure can be calculated as can the 
tension time index (TTI) which is the area under the systolic portion of the pressure waveform per 
minute ( the systolic pressure-time integral), and is an index of systolic stress. Likewise, the 
diastolic pressure-time (20) can be derived and from these variables the subendocardial viability 
index (SEVR) calculated as the ratio diastolic pressure time integral: tension time index.  This 
provides a measure of the relationship between subepicardial and subendocardial blood flow and 
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therefore the potential for myocardial ischaemia.(21) Ejection duration is calculated as the time 
from the foot of the pressure wave to the incisura. 
 
 
 
 
Top Aortic pressure wave synthesized from the measured radial artery pressure wave (applanation 
tonometry) using a generalized transfer function. The abbreviation Ps indicates peak systolic 
pressure; Pi is an inflection point that indicates the beginning upstroke of the reflected pressure 
wave; Pd is minimum diastolic pressure; tp is the round trip travel time of the forward (or incident) 
wave from the ascending aorta to the major reflecting site and back; and tr is the systolic duration 
of the reflected pressure wave. Pulse pressure is (Ps- Pd) = (Pi - Pd) + (Ps - Pi). Augmentation index 
(AIa) = (Ps - Pi)/(Ps- Pd) and wasted LV pressure energy (Ew) = 2.09 tr (Ps - Pi). (Bottom) 
Noninvasive high-fidelity recording of the radial artery pressure wave. The wave has been shifted 
leftward to align with the aortic pressure wave. The variations in the pressure wave, like those of 
the aortic pressure wave, are due to wave reflections from the lower body superimposed on the 
wave. The abbreviation P1 is the sum of the incident (ejected) wave and reflected wave (from 
hand); P2 is the peak of the reflected wave from the lower body minus end-diastolic pressure; P2/P1 
is the radial artery augmentation index (AIr); and TDVP is the difference between the first two peaks 
of the pressure wave and has been used as a measure of arterial stiffness. 
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METHODS: 
We recruited 54 pre-eclamptic women admitted to the William Gilliatt Ward of the Kings College 
Hospital, London and compared them to a control group of 69 women recruited from the Antenatal 
clinic and from the Harris Birthright Research Centre.  
Pre-eclampsia was defined as blood pressure over 140/90 on two consecutive readings atleast 4 
hours apart, edema and proteinuria of atleast 2+ on dipstick or 300 mg/ 24 hr urine collection. 
Superimposed pre-eclampsia was diagnosed if a chronic hypertensive patient’s systolic and/or 
diastolic levels rose ≥ 30 or ≥ 15 mmHg, respectively, and/or if proteinuria appeared de novo or 
increased substantially. Other Laboratory tests done included platelet count, uric acid, Creatinine 
and aspartate aminotransferase.  
The control group comprised of healthy pregnant women with uncomplicated pregnancies that 
were not on treatment and did not have any family history of early heart disease. 
 Maternal age, ethnic group, smoking status, parity, pre-pregnancy weight, current weight, height, 
previous obstetric history, past medical history, drugs, and family history were recorded. 
The study was approved by the Institutional Review Committee and all women gave written 
informed consent. 
The patients were examined after 10 minutes of rest in the left lateral position to avoid compression 
of the Vena Cava from the uterus. 
Peripheral BP was measured in the right arm using an ambulatory blood pressure monitor 
(Microlife Medical 90207, WA, US), which has been validated in pregnancy.22 
Two measurements were taken and averaged. The mean arterial BP (MAP) was then derived from 
the systolic and diastolic BP (SBP, DBP)  
Pulse wave velocity: 
The sygmoCor ( PWV Medical, Sydney, Australia) 23,24  system was used to assess Aortic (carotid-
femoral) and brachial ( carotid- radial ) PWV by applanation tonometry. The PWV was determined 
by sequential acquisition of pressure waveforms from these arteries. The timing was compared 
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with that of the R wave on the simultaneously recorded electrocardiogram (25) The time delay was 
measured automatically by the computer software. The distance travelled by the pulse wave 
between the carotid and femoral arteries was measured in a straight line using a pair of compasses 
to reduce the influence of altered body contours induced by pregnancy. The proximal distance was 
measured from the sternal notch to the sampling site on the carotid artery and the distal distance 
was measured from the sternal notch to the sampling site on the femoral artery. The carotid- to- 
femoral path length was calculated by subtracting the proximal from the distal distance. In the case 
of brachial PWV the proximal distance was from the sternal notch to the sampling site on the 
carotid artery while the distal distance was the measurement from the sternal notch to the sampling 
site of the radial artery. 
Pulse wave velocity was then calculated as the ratio of the distance travelled by the pulse wave 
and the foot-to-foot time delay between the pulse waves and expressed in meters per second.(25) 
For each patient a two waveform recordings were obtained. The mean was then used for statistical 
analysis. 
Pulse Wave Analysis: 
The SphygmoCor system was used for the analysis of the radial pressure wave contour. The radial 
artery was pressed gently at the site of maximal pulsation with the tip of the tonometer containing a 
micromanometer that accurately records the pressure within the artery (SPC-301; Millar 
Instruments, Houston, Tex) 
Aortic waveform, peripheral mean pressure and central pressures were obtained from the radial 
artery waveform by using a transfer function.  
 Augmentation index (AIx), is calculated from the difference between the first and second systolic 
peaks expressed as a percentage of the pulse pressure and is determined by the integrated 
software. Mean arterial blood pressure (MAP) and central systolic, diastolic and pulse pressure 
(CSBP,  CDBP  and CPP) were also determined. Information on first systolic peak and its time (P1, 
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T1), height of the first systolic peak (P1H), second systolic peak and its time (P2, T2), and aortic Tr 
(time between the start of the systolic curve and the inflection point) was also given. 
All the measurements were obtained twice and the mean was used for the statistical analysis.  
The measurements were done by the same operators ( C.K, J.A) and were subjected to quality 
control by the software. 
 
Statistical analysis 
Normality of the distribution of the data was examined with the Kolmogorov-Smirnov test. For those 
parameters that were not normally distributed logarithmic transformation was performed. Data were 
expressed as mean  standard deviation or as median (interquartile range) for normally and non-
normally distributed data respectively. Comparisons between groups were performed using 
unpaired Student t-test or chi-square (χ2) for numerical and categorical data respectively. 
Univariate analyses were performed between AIx, PWV and maternal age, BMI, MAP, heart rate 
(HR), gestational age (GA) at entry, and Tr to look for potential confounders. Multiple regression 
analysis was performed when adjustment for potential confounders thought to be necessary. The 
statistical analyses were performed using the Statistical Package for Social Sciences (Version 
12.0).  
 
RESULTS: 
Recordings were successfully obtained from all women and they all tolerated the studies well. The 
group of women with PE included 20 women with early onset PE, who had to be delivered before 
or at 34 weeks due to the severity of the condition. In all tables, values are given for early and late 
PE, although the comparisons were done between normotensive women and women with PE 
overall.  
The demographic characteristics of the study participants are given in Table 1. Women with PE 
were more likely to be black, with higher BMI and delivered smaller babies earlier, than expected. 
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The hemodynamic parameters are given in Table 2. Compared to normotensive women, women 
with PE had slower HR and longer heart cycle, which was mainly due to longer duration of the 
diastole rather than the ejection duration time. By definition, all blood pressure indices (peripheral 
and central, systolic and diastolic) were significantly higher in women with PE. Peripheral pulse 
pressure (peripheral PP), a valuable surrogate measurement of arterial stiffness, was higher in 
women with PE.  
In women with PE, the height of P1 (the maximum pressure created by the forward-going pressure 
wave), P1H (an index of peak ventricular ejection velocity) and P2 were significantly elevated. The 
increased P2 could also be explained by the shorter aortic Tr, the timing of the reflected wave, 
which causes a shift of the reflected wave earlier into systole. 
The AIx was significantly increased in women with established PE. In a multiple linear regression 
analysis with the AIx as a dependent variable, current PE (p<0.0001) was independently 
associated with increased wave reflection in a model that also included maternal age (p=0.002), 
HR (p<0.0001), GA at entry (p= 0.03) and aortic Tr (p<0.0001). Parity, smoking, ethnic group, BMI 
and MAP were not significant determinants of AIx. The above findings were confirmed with 
univariate analysis of variance, which showed that the difference of AIx between the two groups of 
women was significant even after adjusting for age, HR, GA at entry and aortic Tr. 
The PWV (carotid-radial and carotid-femoral) were significantly higher in women with established 
PE. In a multiple linear backward regression analysis with the PWV (carotid-radial) as a dependent 
variable, current PE was independently associated with increased PWV (p<0.0001) in a model that 
also included age(p<0.0001), MAP (p<0.0001) and black race (p<0.0001). Parity, smoking, BMI, 
HR and GA at entry were not significant predictors of PWV (carotid-radial). The results were similar 
for PWV (carotid-femoral). 
The AIx and PWV (carotid-radial and carotid-femoral) were not correlated with any of the 
haematological or biochemical markers measured in women with established PE (platelets, 
aspartate aminotransferase, creatinine and proteinuria/24h) (data not shown). 
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All the above changes, described above, between normotensive women and those with PE were 
more pronounced, but not necessarily significantly, in women with early onset disease. The 
statistical significance of the comparisons between women with early and late onset disease are 
given in parentheses in Tables 1 and 2. 
 
DISCUSSION: 
A previous study performed in our centre demonstrated that in an uncomplicated pregnancy there 
is a decrease in central systolic and diastolic BP and AIx. These changes appear already in the first 
trimester and reach their nadir in mid-pregnancy and thereafter rise to approximately pre-
pregnancy levels by term. They also found that normal pregnancy is associated with a decline in 
wave reflections within the arterial tree.(26). 
In this study, the pre-eclamptic women had higher central blood pressures than their normal 
controls and the pulse pressure an indicator of arterial stiffness was significantly different between 
the two groups. This confirms the generalised conception that pre-eclampsia is a state of 
vasoconstriction of the peripheral vessels. We also observed an increase in both the PWV in the 
aortic (carotid- femoral PWV) and brachial, (carotid- radial PWV) arteries. An increase in the PWV 
causes an earlier reflection of the pulse wave towards the heart in systole and this is expressed as 
augmentation index which appeared increased in the pre-eclamptic group compared to the control 
group even after having adjusted for the BP and heart rate. Women with pre-eclampsia also had 
smaller babies this is probably due to the reduced plasma volume expansion and placental 
circulation.  
The most common factors that have been reported to be related with increased arterial stiffness in 
the normal population are age and hypertension where central elastic vessels become stiffer, 
diastolic pressure decreases and central systolic and pulse pressures are increased due to 
increased PWV and early return of reflected waves to the heart from the periphery . (27,28) This 
has been thought to be due to various causes occurring over a long period of time. These include 
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reduced elastin, increased collagen, increased calcium content in the arterial wall, increased 
creatinine and norepinephrine, reduced ß- receptor tone of the smooth muscle cells, reduced 
release of nitric oxide (NO) and increased release of endotelin. (29,31) 
The increased arterial stiffness in pre-eclampsia could be related to endothelial dysfunction.(30,31) 
The endothelium has shown to play an important role in the regulation of arterial stiffness by 
releasing vasoactive substances like NO.(32,33) whose production is reduced in pre-eclampsia. 
The association of arterial stiffness and endothelial dysfunction has been demonstrated in a 
previous study that reports reduced pulse wave reflection induced by the administration of glycerly 
trinitrate. (34,35)  
In addition, other characteristics of pre-eclampsia such as increased levels of homocysteine (36) 
and insulin resistance (37) could also be contributing factors to the observed increased maternal 
arterial stiffness, as all these factors have been associated with increased arterial stiffness in non-
pregnant populations (38,39). 
We have also demonstrated that women with established pre-eclampsia have increased PWV both 
in the carotid-radial and carotid-femoral pathways, even after adjustment for possible confounders. 
Previous studies assessing the arterial stiffness of other vascular pathways such as base of the 
aorta to popliteal artery (40) and abdominal aorta (41) have confirmed increased arterial stiffness in 
women with established PE. These findings suggest that large conduit arteries, together with the 
peripheral vasculature, are also involved in the aberrant hemodynamic adaptation of pre-
eclampsia.  
Moreover, studies in former pre-eclamptic women have demonstrated increased PWV (carotid-
femoral) four months following delivery (42) and persistence of maternal endothelial dysfunction 
(43) years after the index pregnancy. The increased arterial stiffness and endothelial dysfunction 
during PE and probably following a pregnancy complicated by pre-eclampsia (42,43) could provide 
a plausible link between this condition and the increased risk of cardiovascular events that these 
women experience later on in life (44).  
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In summary, we have shown that PE is associated with increased maternal systemic arterial 
stiffness, as assessed by the method of applanation tonometry. Although arterial stiffening 
characterizes women with established pre-eclampsia, it is uncertain whether this is the cause or 
the consequence of the disease. To what extent this method can be used to identify women at risk 
prior to the development of the condition remains to be determined. 
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TABLES: 
 
Table 1. Demographic characteristics of the study populations. Values are given for late and early 
pre-eclampsia (PE). Comparisons were performed between normotensive women and women with 
PE overall and also between women with early and later onset PE (last P Value column). Data are 
presented as mean±SD or as median (interquartile range) for normally and non-normally 
distributed data respectively.   
Parameter Controls 
(N=69) 
PE (N=54) 
Late PE (N=34)     Early PE (N=20)                    
P Value 
(PE overall) 
Maternal age (yrs) 30.76 30.57  30.76.6 0.9 
Ethnic group 
     White, n (%) 
     Black, n (%) 
     Others, n (%) 
 
35 (50.7) 
28 (40.6) 
6 (8.7) 
 
13 (38.2) 
16 (47.1) 
5 (14.7) 
 
1 (5) 
17 (85) 
2 (10) 
0.02 
Smoking, n (%) 15 (21.7) 7 (20.6) 2 (10) 0.4 
Nulliparity, n (%) 43 (62.3) 21 (61.8) 9 (45) 0.4 
Maternal height (m) 1.60.05 1.60.06  1.60.05 0.98 
Maternal weight (kg) 7512.6 81.814.4 83.614.5 0.003 
Body mass index (kg/m2) 284.4 30.54.8 315.4 0.002 
Gestational age at entry (days) 22136 25512 20023 0.02 
Gestational age at delivery 
(days) 
281 (273-
286) 
262 (256-
270) 
210 (196-227) <0.0001 
Birthweight (centiles) 59.6 (31.8-
76) 
20.4 (6.2-
57.3) 
1.5 (0.1-7.8) <0.0001 
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Table 2: Vascular parameters of early and late PET 
Parameter Pregnant controls 
(N=69) 
PE (N=54) 
Late PE (N=34)                  Early PE (N=20)                           
P Value 
Heart rate (bpm) 81  11.1 75.7  11.1  71.913.1 0.002 (NS) 
Heart cycle (ms) 749.9116.2 810.1123 859.1152.7 0.001 (NS) 
Ejection duration (msec) 312.6  29.7  311  25.7 324.721.8 0.48 (NS) 
Diastole time (msec) 437.3  97.4 499  105.7 534.4138.1 <0.0001 (NS) 
PSBP (mmHg) 114.810.3 13813.3 14416.5 <0.0001(NS) 
PDBP (mmHg) 69.47.9 88.47.2 91.310.5 <0.0001(NS) 
Mean arterial pressure (mmHg) 84.58.1 104.98.5 108.911.8 <0.0001(NS)  
PP (mmHg) 45.47.3 49.69.9 52.710.4 0.001 (NS) 
CSBP (mmHg) 96.5 (89-102.2) 125.2 (120-134) 133.7 (128.6-138.3) <0.0001 (0.004) 
CDBP  (mmHg) 68 (64-71) 89.2 (82-93) 91 (84.1-102) <0.0001 (0.06) 
CPP (mmHg) 27 (24.2-31.5) 36.2 (30.2-44.1) 43.5 (37.7-47.8) <0.0001 (0.19) 
P1H (mmHg) 25 (23.5-28.7) 27.7 (24-30.5) 32 (25.7-34.3) 0.002 (0.03) 
P1 (mmHg) 959.4 116.27.7 125.611.7 <0.0001 (0.001) 
P2 (mmHg) 96.411.6 12612.5 136.813.5 <0.0001 (0.005) 
Aortic T1 (msec) 115.317.3 110.29.9 105.311.7 0.01(NS) 
Aortic T2 (msec) 195.423.9 215.122.5 219.425.7 <0.0001(NS) 
Aortic Tr (msec) 152.5(144.7-166) 141.5 (134.2-146.5) 136.5 (132.5-145.3) <0.0001(NS) 
SEVR (ratio) 119.419.4 137.522.8 138.631.6 <0.0001 (NS) 
Augmentation Index (AIX) % 413.6  23.8  9.9  25.111.2 <0.0001(NS) 
Amplification ratio (PPP/CPP) 1.60.1 1.30.1 1.30.1 <0.0001 (NS) 
Non-augmented amplification 
ratio (P1-CDBP) 
1.7 (1.6-1.8) 1.7 (1.7-1.7) 1.7 (1.7-1.8) 0.17 (NS) 
PWV (carotid-radial)(m/sec) 7.51.2  9.5 1.1 9.30.7 <0.0001 (NS) 
PWV (carotid-femoral)(m/sec) 5.50.7 7.2 1.4 7.30.9 <0.0001 (NS) 
 
DBP: diastolic blood pressure; CDBP: central diastolic blood pressure; PDBP: peripheral diastolic blood 
pressure 
SBP: systolic blood pressure; CSBP: central systolic blood pressure; PSBP: peripheral systolic blood 
pressure  
PP: pulse pressure; CPP: central pulse pressure 
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Figure 1:  
 
Box and whisker plot comparing the maternal augmentation index between normotensive controls 
and women with established pre-eclampsia (*p<0.0001). Boxes represent inter-quartile range, 
where the line represents the median. Whiskers at top and bottom of the box represent the highest 
and lowest values.  
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Figure 2:  
Box and whisker plots comparing the maternal pulse wave velocity of the carotid-radial and carotid-
femoral part of the arterial tree between normotensive controls and women with established pre-
eclampsia (*p<0.0001). Boxes represent inter-quartile range, where the line represents the median. 
Whiskers at top and bottom of the box represent the highest and lowest values.  
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